Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2018 1
2019 3
2020 61
Text availability
Article attribute
Article type
Publication date

Search Results

65 results
Results by year
Filters applied: . Clear all
Page 1
Compassionate Use of Remdesivir for Patients with Severe Covid-19.
Grein J, Ohmagari N, Shin D, Diaz G, Asperges E, Castagna A, Feldt T, Green G, Green ML, Lescure FX, Nicastri E, Oda R, Yo K, Quiros-Roldan E, Studemeister A, Redinski J, Ahmed S, Bernett J, Chelliah D, Chen D, Chihara S, Cohen SH, Cunningham J, D'Arminio Monforte A, Ismail S, Kato H, Lapadula G, L'Her E, Maeno T, Majumder S, Massari M, Mora-Rillo M, Mutoh Y, Nguyen D, Verweij E, Zoufaly A, Osinusi AO, DeZure A, Zhao Y, Zhong L, Chokkalingam A, Elboudwarej E, Telep L, Timbs L, Henne I, Sellers S, Cao H, Tan SK, Winterbourne L, Desai P, Mera R, Gaggar A, Myers RP, Brainard DM, Childs R, Flanigan T. Grein J, et al. N Engl J Med. 2020 Apr 10:NEJMoa2007016. doi: 10.1056/NEJMoa2007016. Online ahead of print. N Engl J Med. 2020. PMID: 32275812 Free PMC article.
Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease.
Agostini ML, Andres EL, Sims AC, Graham RL, Sheahan TP, Lu X, Smith EC, Case JB, Feng JY, Jordan R, Ray AS, Cihlar T, Siegel D, Mackman RL, Clarke MO, Baric RS, Denison MR. Agostini ML, et al. mBio. 2018 Mar 6;9(2):e00221-18. doi: 10.1128/mBio.00221-18. mBio. 2018. PMID: 29511076 Free PMC article.
2020 May 11. Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006–. Drugs and Lactation Database (LactMed). 2006–. PMID: 32401466 Free Books & Documents. Review.
Arguments in favour of remdesivir for treating SARS-CoV-2 infections.
Ko WC, Rolain JM, Lee NY, Chen PL, Huang CT, Lee PI, Hsueh PR. Ko WC, et al. Int J Antimicrob Agents. 2020 Apr;55(4):105933. doi: 10.1016/j.ijantimicag.2020.105933. Epub 2020 Mar 6. Int J Antimicrob Agents. 2020. PMID: 32147516 Free PMC article. No abstract available.
Remdesivir as a possible therapeutic option for the COVID-19.
Al-Tawfiq JA, Al-Homoud AH, Memish ZA. Al-Tawfiq JA, et al. Travel Med Infect Dis. 2020 Mar-Apr;34:101615. doi: 10.1016/j.tmaid.2020.101615. Epub 2020 Mar 5. Travel Med Infect Dis. 2020. PMID: 32145386 Free PMC article. No abstract available.
Remdesivir (GS-5734) protects African green monkeys from Nipah virus challenge.
Lo MK, Feldmann F, Gary JM, Jordan R, Bannister R, Cronin J, Patel NR, Klena JD, Nichol ST, Cihlar T, Zaki SR, Feldmann H, Spiropoulou CF, de Wit E. Lo MK, et al. Sci Transl Med. 2019 May 29;11(494):eaau9242. doi: 10.1126/scitranslmed.aau9242. Sci Transl Med. 2019. PMID: 31142680 Free PMC article.
Remdesivir in covid-19.
Ferner RE, Aronson JK. Ferner RE, et al. BMJ. 2020 Apr 22;369:m1610. doi: 10.1136/bmj.m1610. BMJ. 2020. PMID: 32321732 No abstract available.
65 results
Jump to page